Patent · US Active

Liquid urease inhibitor formulations

US11053170B2 · kind B2 · utility

0Cited by
3References
24Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 24, 2017
Grant dateJul 6, 2021
Priority date
Expiry dateOct 27, 2037

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02P60/21
  • WIPO fieldBasic materials chemistry
  • WIPO sectorChemistry

Abstract

The present application generally relates to a method for the manufacture of a liquid composition essentially consisting of an organic solvent of the type glycol and a urease inhibitor of the type phosphoric triamide and products obtained therewith.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.